Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study
Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study
Background Data on the pharmacological treatment of trichotillomania are limited. Milk thistle has antioxidant properties and showed promise in trichotillomania in a prior case report. The goal of the current study was to determine the efficacy and tolerability of silymarin in children and adults with trichotillomania. Methods Twenty individuals (19 [95.0%] women; 16 adults; mean age, 27.9 [11.5] years) with trichotillomania entered a 12-week, double-blind, placebo-controlled crossover study (6 weeks of milk thistle and 6 weeks of placebo with a 1-week wash-out in between). Dosing of milk thistle ranged from 150 mg twice a day to 300 mg twice a day. Subjects were assessed with the National Institute of Mental Health Trichotillomania Severity Scale (primary outcome), the Massachusetts General Hospital Hair Pulling Scale, Clinical Global Impression scale, and measures of depression, anxiety, and psychosocial functioning. Outcomes were examined using linear mixed models with a random intercept for subject and t tests. Results There were no statistically significant treatment type-by-time interactions for the main outcome measure, but significant effects were seen for secondary measures (eg, time spent pulling per day for the past week). From baseline to week 6, there was a significant decrease in Clinical Global Impression severity for the milk thistle group but not in the placebo group. Conclusions This trial failed to show that milk thistle was more effective than placebo on the main outcome measure, but milk thistle did demonstrate significant improvements on select secondary outcome measures. These findings may shed light on important neurochemical targets worthy of future investigation.
milk thistle, natural supplement, silymarin, treatment, trichotillomania
129-134
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Redden, Sarah A.
f2109178-7158-46c7-971f-4a602a3adf59
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
1 March 2019
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Redden, Sarah A.
f2109178-7158-46c7-971f-4a602a3adf59
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Grant, Jon E., Redden, Sarah A. and Chamberlain, Samuel R.
(2019)
Milk Thistle Treatment for Children and Adults with Trichotillomania: a Double-Blind, Placebo-Controlled, Crossover Negative Study.
Journal of Clinical Psychopharmacology, 39 (2), .
(doi:10.1097/JCP.0000000000001005).
Abstract
Background Data on the pharmacological treatment of trichotillomania are limited. Milk thistle has antioxidant properties and showed promise in trichotillomania in a prior case report. The goal of the current study was to determine the efficacy and tolerability of silymarin in children and adults with trichotillomania. Methods Twenty individuals (19 [95.0%] women; 16 adults; mean age, 27.9 [11.5] years) with trichotillomania entered a 12-week, double-blind, placebo-controlled crossover study (6 weeks of milk thistle and 6 weeks of placebo with a 1-week wash-out in between). Dosing of milk thistle ranged from 150 mg twice a day to 300 mg twice a day. Subjects were assessed with the National Institute of Mental Health Trichotillomania Severity Scale (primary outcome), the Massachusetts General Hospital Hair Pulling Scale, Clinical Global Impression scale, and measures of depression, anxiety, and psychosocial functioning. Outcomes were examined using linear mixed models with a random intercept for subject and t tests. Results There were no statistically significant treatment type-by-time interactions for the main outcome measure, but significant effects were seen for secondary measures (eg, time spent pulling per day for the past week). From baseline to week 6, there was a significant decrease in Clinical Global Impression severity for the milk thistle group but not in the placebo group. Conclusions This trial failed to show that milk thistle was more effective than placebo on the main outcome measure, but milk thistle did demonstrate significant improvements on select secondary outcome measures. These findings may shed light on important neurochemical targets worthy of future investigation.
This record has no associated files available for download.
More information
Published date: 1 March 2019
Additional Information:
Publisher Copyright:
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
Keywords:
milk thistle, natural supplement, silymarin, treatment, trichotillomania
Identifiers
Local EPrints ID: 493288
URI: http://eprints.soton.ac.uk/id/eprint/493288
ISSN: 0271-0749
PURE UUID: c3188388-4500-48eb-a4a9-62c6da49368e
Catalogue record
Date deposited: 29 Aug 2024 16:42
Last modified: 30 Aug 2024 02:00
Export record
Altmetrics
Contributors
Author:
Jon E. Grant
Author:
Sarah A. Redden
Author:
Samuel R. Chamberlain
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics